Posted: Tuesday, April 22, 2014 1:42 PM ET
By: Julian Close
Traders returned from the long Easter weekend to discover news that the pharma supergiant Pfizer had made a $101 billion offer for mere pharma giant, AstraZeneca (AZN). The deal was rejected, but talks may be continuing, as we reported yesterday. What is now clear is that the deal signaled other companies in the big pharma industry that the gates were open, and it was time to act lest their own deals be shut out, hence, just 24 hours later, we have two more huge 11-digit deals to report on in addition to the one colossal 12-digit deal.
Wading... Read More